Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:3081704.
doi: 10.1155/2016/3081704. Epub 2016 Jul 25.

Clozapine Can Be the Good Option in Resistant Mania

Affiliations

Clozapine Can Be the Good Option in Resistant Mania

S M Yasir Arafat et al. Case Rep Psychiatry. 2016.

Abstract

Bipolar mood disorder is a mental disorder with a lifetime prevalence rate of about 1% in the general population and there are still a proportion of individuals who suffer from bipolar mood disorders that are resistant to standard treatment. Reporting clozapine responsive mania that was not responding to two previous consecutive atypical antipsychotics and one typical antipsychotic was aimed at. A 17-year-old male manic patient was admitted into the psychiatry inpatient department and was nonresponsive to Risperidone 12 mg daily for 4 weeks, Olanzapine 30 mg daily for 3 weeks, and Haloperidol 30 mg daily for 3 weeks, along with valproate preparation 1500 mg daily. He was started on clozapine as he was nonresponsive to Lithium in previous episodes and did not consent to starting Electroconvulsive Therapy (ECT). He responded adequately to 100 mg clozapine and 1500 mg valproate preparation and remission happened within 2 weeks of starting clozapine. Clozapine can be a good option for resistant mania and further RCT based evidences will strengthen the options in treating resistant mania.

PubMed Disclaimer

References

    1. Merikangas K. R., Jin R., He J. P., et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Archives of General Psychiatry. 2011;68(3):241–251. doi: 10.1001/archgenpsychiatry.2011.12. - DOI - PMC - PubMed
    1. Gitlin M. J. Treatment-resistant bipolar disorder. Bulletin of the Menninger Clinic. 2001;65(1):26–40. doi: 10.1521/bumc.65.1.26.18709. - DOI - PubMed
    1. Chou J. Treatment-resistant bipolar disorder. Psychiatric Times, 2001, http://www.psychiatrictimes.com/bipolar-disorder/treatment-resistantbipo....
    1. Yatham L. N., Kennedy S. H., O'Donovan C., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patienst with bipolar disorder: consensus and controversies. Bipolar Disorders. 2005;7(3):5–69. - PubMed
    1. Hirschfeld R. M. A., Bowden C. L., Gitlin M., et al. Practice Guideline for the Treatment of Patients With Bipolar Disorder. 2nd. American Psychiatric Association; 2002.

LinkOut - more resources